期刊文献+

可溶性CD40配体与心脑血管疾病关系的研究进展 被引量:7

Progress on Relationship Between sC D40L and Cardiac- cerebral Vascular Disease
下载PDF
导出
摘要 可溶性CD40配体(s CD40L)是一种跨膜糖蛋白,属肿瘤坏死因子家族,其是由m CD40L在蛋白水解酶的作用下裂解而成,并以三聚体的形式存在。有研究发现,s CD40L可增加动脉粥样硬化发生风险,且与心脑血管疾病的发生发展密切相关。本文综述了s CD40L与动脉粥样硬化、心血管疾病及脑血管疾病关系的研究进展,旨在为心脑血管疾病的防治提供新的思路。 s CD40 L is one kind of transmembrane glycoproteins,belongs to tumor necrosis factor family,comes from proteolytic enzyme- induced cracking of m CD40 L, mainly performs as tripolymer. Recent research found that, s CD40 L can increase the risk of atherosclerosis, is closely correlated with cardiac- cerebral vascular disease. This paper reviewed the correlations of s CD40 L with atherosclerosis,cardiovascular disease and cerebrovascular disease,in order to provide new clew for the prevention and treatment of cardiac- cerebral vascular disease.
出处 《实用心脑肺血管病杂志》 2016年第4期5-8,共4页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 可溶性CD40配体 动脉粥样硬化 心血管疾病 脑血管障碍 Soluble CD40 ligand Atherosclerosis Cardiovascular disease Cerebrovascular disorders
  • 相关文献

参考文献59

  • 1Noclle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand receptor pair for thymus - dependent B cell activation [ J ]. Immunol Today, 1992, 13 (11) : 431 -433.
  • 2Anand SX, Viles - Gonzalez JF, Badimon J J, et al. Membrane - associated CIMOL and sCIMOL in atherothrombotic disease [ J ]. Thromb Haemost, 2003, 90 (3): 377-384.
  • 3Chart FK, Chun HJ, Zheng L, et al. A domain in TNF receptors that mediates ligand - independent receptor assembly and signaling [J]. Science, 2000, 288 (5475): 2351-2354.
  • 4Schonbeck U, Libby E The CIMO/CD154 reeeptor/ligand dyed [J]. Cell Mol Life Sci, 2001, 58 (1) : 4 -43.
  • 5Sehonbeck U, Gerdes N, Varo N, et al. Oxidized low- density lipoprotein augments and 3 - hydroxy - 3 - methylglutaryl coenzyme A cations noted, reductase inhibitors limit CIMO and CD40L expression in human vascular cells [J]. Circulation, 2002, 106 (28) : 88 -93.
  • 6Schonbeck U, Libby P. CIM0 signaling and plaque instability [ J]. Cire Res, 2001, 89 (12): 1092-1103.
  • 7Hermann A, Ranch BH, Braun M, et al. Platelet CIM0 ligand (CD40L) subcellula rlocalization, regulation of expression, and inhibition by clopidogrel [J]. Platelets, 2001, 12 (2): 74-82.
  • 8Schafer A, Alp N J, Cai S, et al. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24 (9) : 1720 - 1726.
  • 9Andre P, Prasad KS, Denis CV, et al. CIMOL stabilizes arterial thrombi by a b3 intcgrin - dependent mechanism [ J ]. Nat Med, 2002, 8 (3) : 247 - 252.
  • 10Ludewig B, Henn V, Schroder JM, et al. Induction, regulation, and function of soluble TRAP ( CIMO ligand) during interaction of primary CD4^+ CD45RA^+ T cells with dendritic cells [J]. Eur J Immunol, 1996, 26 (12): 3137-3143.

同被引文献60

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部